Clinical Trials Logo

Clinical Trial Summary

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients. This study was undertaken to investigate the source of these serum tumor markers.


Clinical Trial Description

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients. This study was undertaken to investigate the source of these serum tumor markers.We hypothesis that these tumor markers are released from the lung. The broncholveolr lvge fluid levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 were measured in the interstitial lung disease patients before lung transplantation. The immunohistochemical test was performed in the specimen lung after lung transplantation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04597814
Study type Observational
Source The First Affiliated Hospital of Guangzhou Medical University
Contact
Status Completed
Phase
Start date January 1, 2019
Completion date October 15, 2020